Israel
# |
Name |
Revenue |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 15.85 B
|
Dec. 31, 2023 | USD 20.86 | -2.64% |
|
Israel |
|
2 |
USD 452.63 M
|
Dec. 31, 2023 | USD 0.52 | -0.27% |
|
Israel |
|
3 |
USD 256.38 M
|
Dec. 31, 2023 | USD 20.06 | -0.66% |
|
Israel |
|
4 |
USD 142.52 M
|
Dec. 31, 2023 | USD 7.30 | -3.84% |
|
Israel |
|
5 |
USD 97.92 M
|
Dec. 31, 2023 | USD 1.65 | -1.71% |
|
Israel |
|
6 |
USD 88.59 M
|
Dec. 31, 2023 | USD 3.80 | 0.26% |
|
Israel |
|
7 |
USD 57.08 M
|
Dec. 31, 2023 | USD 2.73 | -8.00% |
|
Israel |
|
8 |
USD 50.31 M
|
Dec. 31, 2023 | USD 4.46 | 11.46% |
|
Israel |
|
9 |
USD 41.40 M
|
Dec. 31, 2023 | USD 0.84 | 0.91% |
|
Israel |
|
10 |
USD 36.82 M
|
Dec. 31, 2023 | USD 2.26 | -2.59% |
|
Israel |
|
11 |
USD 33.46 M
|
Dec. 31, 2023 | USD 1.85 | 10.75% |
|
Israel |
|
12 |
USD 31.79 M
|
Dec. 31, 2023 | USD 4.83 | -0.52% |
|
Israel |
|
13 |
USD 25.06 M
|
Dec. 31, 2023 | USD 1.20 | 0.92% |
|
Israel |
|
14 |
USD 21.61 M
|
Dec. 31, 2023 | USD 2.04 | NA |
|
Israel |
|
15 |
USD 18.69 M
|
Dec. 31, 2023 | USD 19.02 | 3.99% |
|
Israel |
|
16 |
USD 16.84 M
|
Dec. 31, 2023 | USD 6.13 | 0.95% |
|
Israel |
|
17 |
USD 12.18 M
|
Dec. 31, 2023 | USD 0.11 | 0.81% |
|
Israel |
|
18 |
USD 10.96 M
|
Dec. 31, 2023 | USD 3.84 | -2.29% |
|
Israel |
|
19 |
USD 9.90 M
|
Dec. 31, 2023 | USD 7.48 | 1.22% |
|
Israel |
|
20 |
USD 9.58 M
|
Dec. 31, 2023 | USD 0.08 | 0.04% |
|
Israel |
|
21 |
USD 8.23 M
|
Dec. 31, 2023 | USD 0.07 | 0.45% |
|
Israel |
|
22 |
USD 6.51 M
|
Dec. 31, 2023 | USD 5.51 | -1.08% |
|
Israel |
|
23 |
USD 6.21 M
|
Dec. 31, 2023 | USD 2.67 | 0.76% |
|
Israel |
|
24 |
USD 5.64 M
|
Dec. 31, 2023 | USD 1.59 | 0.10% |
|
Israel |
|
25 |
USD 4.80 M
|
Dec. 31, 2023 | USD 0.01 | -11.50% |
|
Israel |
|
26 |
USD 3.23 M
|
Dec. 31, 2023 | USD 1.24 | 5.08% |
|
Israel |
|
27 |
USD 2.77 M
|
Dec. 31, 2023 | USD 1.21 | 0.04% |
|
Israel |
|
28 |
USD 2.75 M
|
Dec. 31, 2023 | USD 2.58 | -3.90% |
|
Israel |
|
29 |
USD 2.00 M
|
Dec. 31, 2023 | USD 0.87 | 0.07% |
|
Israel |
|
30 |
USD 1.36 M
|
Dec. 31, 2023 | USD 0.09 | -0.28% |
|
Israel |
|
31 |
USD 1.32 M
|
Dec. 31, 2023 | USD 0.73 | -4.24% |
|
Israel |
|
32 |
USD 743.00 K
|
Dec. 31, 2023 | USD 0.01 | 0.04% |
|
Israel |
|
33 |
USD 508.96 K
|
Dec. 31, 2023 | USD 0.19 | 1.64% |
|
Israel |
|
34 |
USD 326.00 K
|
June 30, 2024 | USD 4.33 | -2.68% |
|
Israel |
|
35 |
USD 283.00 K
|
Dec. 31, 2023 | USD 0.51 | 17.58% |
|
Israel |
|
36 |
USD 241.26 K
|
Dec. 31, 2023 | USD 0.20 | -2.14% |
|
Israel |
|
37 |
USD 195.80 K
|
Dec. 31, 2023 | USD 0.02 | -1.36% |
|
Israel |
|
38 |
USD 39.11 K
|
Dec. 31, 2023 | USD 0.19 | -0.67% |
|
Israel |
|
39 |
USD 4.41 K
|
Dec. 31, 2023 | USD 0.20 | 2.02% |
|
Israel |
|
40 |
USD 0.00
|
Dec. 31, 2023 | USD 1.16 | -2.88% |
|
Israel |
|
41 |
USD 0.00
|
Dec. 31, 2023 | USD 0.00 | -99.04% |
|
Israel |
|
42 |
USD 0.00
|
Dec. 31, 2023 | USD 1.56 | -3.11% |
|
Israel |
|
43 |
USD 0.00
|
Dec. 31, 2023 | USD 4.00 | 8.11% |
|
Israel |
|
44 |
USD 0.00
|
Dec. 31, 2023 | USD 1.90 | -4.04% |
|
Israel |
|
45 |
USD 0.00
|
Dec. 31, 2023 | USD 0.09 | -4.99% |
|
Israel |
|
46 |
USD 0.00
|
Dec. 31, 2023 | USD 0.02 | 1.63% |
|
Israel |
|
47 |
USD 0.00
|
Dec. 31, 2023 | USD 0.51 | -4.99% |
|
Israel |
|
48 |
USD 0.00
|
Dec. 31, 2023 | USD 0.04 | -0.60% |
|
Israel |
|
49 |
USD 0.00
|
Dec. 31, 2023 | USD 2.74 | -3.52% |
|
Israel |
|
50 |
USD 0.00
|
Dec. 31, 2023 | USD 1.03 | -0.96% |
|
Israel |
The Health Care company in Israel with the highest Revenue is Teva Pharmaceutical Industries Limited (Tel Aviv Stock Exchange: TEVA.TA) at USD 15.85 B.
The Health Care company in Israel with the lowest Revenue is Entera Bio Ltd. (NasdaqCM: ENTX) at USD 0.00.
The top 10 Health Care companies in Israel by Revenue are Teva Pharmaceutical Industries Limited, Novolog (Pharm-Up 1966) Ltd, Ilex Medical Ltd, Kamada Ltd., InterCure Ltd., Rekah Pharmaceutical Industry Ltd., SHL Telemedicine Ltd., SofWave Medical Ltd., Seach Medical Group Ltd and IM Cannabis Corp..
The bottom 10 Health Care companies in Israel by Revenue are Entera Bio Ltd., Scinai Immunotherapeutics Ltd., Galmed Pharmaceuticals Ltd., PolyPid Ltd., Kadimastem Ltd, Nextgen Biomed Ltd, Beeio Honey Ltd, NeuroSense Therapeutics Ltd., PainReform Ltd. and Bonus BioGroup Ltd..